Gerald Zernig, Prof Dr

Department of Pharmacology, Medical University of Innsbruck, Innsbruck, Austria; Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria; Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Task Force “Therapeutic Drug Monitoring”

JCP
Therapeutic Reference Range for Olanzapine
Systematic Review

July 19, 2023

A therapeutic reference range of 20–40 ng/mL for oral and long-acting injectable olanzapine yields optimal treatment effects in schizophrenia spectrum disorders. Dose reduction is not needed above 40 ng/mL...
Katja Wesner, Christoph Hiemke, Niels Bergemann, et al
JCP
Consensus Statement

May 19, 2020

The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this...
Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, et al
JCP
Original Research

July 21, 2009

Read a crossover study comparing of Pharmacokinetic Profiles of brand-name and generic Citalopram and Venlafaxine antidepressants.
Franck Chenu, Lisa A. Batten, Gerald Zernig, et al
JCP
Article

February 15, 2006

Claudia M. Klier, Brigitte Schmid-Siegel, Miriam R. Schäfer, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe